SGHERZA, NICOLA, et al. “Implications of Interleukin-6 (IL-6)-Blockade for Severe COVID-19 Infection in Patients With Multiple Myeloma”. Acta Biomedica Atenei Parmensis, vol. 92, no. 2, May 2021, p. e2021205, https://doi.org/10.23750/abm.v92i2.11395.